Michael Bruckman/LinkedIn
Dec 17, 2025, 05:54
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn:
”Fantastic to see platelet-inspired nanoparticles gaining attention!
This work with Case Western Reserve University and Haima Therapeutics demonstrates how targeted drug delivery at sites of injury can dramatically improve outcomes; in this case, enhancing implanted electrode performance.
Excited about the broad potential of this platform, from neuroscience to trauma care and beyond.”
Read the full article here.
Article: Platelet-inspired nanoparticle delivers drugs directly where they are needed
Authors: Julia Rock-Torcivia
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic